Join this webinar to learn about a new report from the National Academies of Sciences, Engineering, and Medicine. The report describes the new types of biotechnology products likely to emerge over the next 5-10 years and assesses whether future products could pose different types of risks relative to existing products. It also identifies the scientific capabilities, tools, and expertise needed to support the oversight of these products by the U.S. regulatory system. The Chair of the report’s authoring committee, Dr. Richard M. Murray of the California Institute of Technology, will present the report’s findings and will be joined in Q&A by Dr. Steven P. Bradbury, of Iowa State University and Dr. Mary E. Maxon of the, Lawrence Berkeley National Laboratory.